AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,447,000 | +57.3% | 1,607,641 | +29.4% | 0.00% | – |
| Q3 2016 | $920,000 | -37.8% | 1,242,644 | +8.3% | 0.00% | – |
| Q2 2016 | $1,480,000 | +572.7% | 1,147,310 | +1072.1% | 0.00% | – |
| Q1 2016 | $220,000 | -40.1% | 97,883 | -6.7% | 0.00% | – |
| Q4 2015 | $367,000 | +27.0% | 104,944 | +5.1% | 0.00% | – |
| Q3 2015 | $289,000 | +4.0% | 99,898 | -14.7% | 0.00% | – |
| Q2 2015 | $278,000 | -96.8% | 117,157 | -89.8% | 0.00% | -100.0% |
| Q1 2015 | $8,674,000 | +119.5% | 1,151,987 | -0.0% | 0.00% | +100.0% |
| Q4 2014 | $3,952,000 | +12.8% | 1,152,331 | +16.1% | 0.00% | 0.0% |
| Q3 2014 | $3,503,000 | -57.7% | 992,386 | +0.0% | 0.00% | -50.0% |
| Q2 2014 | $8,283,000 | +23.3% | 992,000 | -6.3% | 0.00% | 0.0% |
| Q1 2014 | $6,720,000 | +11.5% | 1,058,219 | +25.2% | 0.00% | 0.0% |
| Q4 2013 | $6,029,000 | +2.3% | 845,538 | +7.6% | 0.00% | 0.0% |
| Q3 2013 | $5,895,000 | +46.8% | 786,065 | +12.9% | 0.00% | +100.0% |
| Q2 2013 | $4,017,000 | – | 696,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |